These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 1532771)

  • 41. Pharmacokinetics of calcium antagonists under development.
    Abernethy DR; Schwartz JB
    Clin Pharmacokinet; 1988 Jul; 15(1):1-14. PubMed ID: 3042243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Barnidipine.
    Malhotra HS; Plosker GL
    Drugs; 2001; 61(7):989-96; discussion 997-8. PubMed ID: 11434453
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily.
    Faulkner JK; McGibney D; Chasseaud LF; Perry JL; Taylor IW
    Br J Clin Pharmacol; 1986 Jul; 22(1):21-5. PubMed ID: 2943308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcium antagonists. Pharmacokinetic properties.
    Kates RE
    Drugs; 1983 Feb; 25(2):113-24. PubMed ID: 6339196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-ischaemic properties of amlodipine, a new calcium antagonist, in patients with severe coronary artery disease: a prospective trial.
    Navarro Estrada J; Saglietti H; Dimarco M; Casabé H; Oliveri R
    Postgrad Med J; 1991; 67 Suppl 5():S52-3. PubMed ID: 1839441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical safety and efficacy of once-daily amlodipine for chronic stable angina pectoris.
    Glasser SP; West TW
    Am Heart J; 1989 Nov; 118(5 Pt 2):1127-8. PubMed ID: 2530871
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacokinetics of amlodipine in hypertensive patients undergoing haemodialysis.
    Kungys G; Naujoks H; Wanner C
    Eur J Clin Pharmacol; 2003 Aug; 59(4):291-5. PubMed ID: 12845505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Therapy of mild to moderate hypertension. Efficacy and tolerance of Amlodipine in comparison with the combination nifedipine/mefruside].
    Höfling B; Häringer E; Herrmann W; Pieske H; Pieske R; Philippi M
    Fortschr Med; 1991 May; 109(15):327-30. PubMed ID: 1830287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effectiveness and tolerance of amlodipine in treatment of patients with mild to moderate hypertension. Results of a long-term study with a new calcium antagonist].
    Habeler G; Lenzhofer R; Pall H; Tomaschek A; Ziebart-Schroth A; Zirm B; Ganzinger U
    Wien Klin Wochenschr; 1992; 104(1):16-20. PubMed ID: 1532108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absorption of amlodipine unaffected by food. Solid dose equivalent to solution dose.
    Faulkner JK; Hayden ML; Chasseaud LF; Taylor T
    Arzneimittelforschung; 1989 Jul; 39(7):799-801. PubMed ID: 2528959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolism and kinetics of amlodipine in man.
    Beresford AP; McGibney D; Humphrey MJ; Macrae PV; Stopher DA
    Xenobiotica; 1988 Feb; 18(2):245-54. PubMed ID: 2967593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women.
    Filgueira GCO; Filgueira OAS; Carvalho DM; Marques MP; Moisés ECD; Duarte G; Lanchote VL; Cavalli RC
    Br J Clin Pharmacol; 2017 Jul; 83(7):1571-1579. PubMed ID: 28042936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amlodipine in hypertension: an overview of the clinical dossier.
    Julius S
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S27-33. PubMed ID: 2467123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A haemodynamic dose finding study with a new slow-calcium channel blocker (amlodipine) in coronary artery disease.
    Frais MA; Silke B; Verma SP; Sharma SK; Reynolds G; Jackson NC; Taylor SH
    Herz; 1986 Dec; 11(6):351-8. PubMed ID: 2950040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetic study of benidipine hydrochloride in rats and dogs.
    Kobayashi H; Kobayashi S; Inoue A; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1750-3. PubMed ID: 3219154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The clinical pharmacology and efficacy of the new Soviet calcium antagonist foridon].
    Kukes VG; Rumiantsev AS; Gneushev ET; Al'perovich BR; Svetyĭ LI; Nasyrov MN; Taratuta TV
    Ter Arkh; 1990; 62(10):138-42. PubMed ID: 2084878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Photochemical stabilities of some dihydropyridine calcium-channel blockers in powdered pharmaceutical tablets.
    Kawabe Y; Nakamura H; Hino E; Suzuki S
    J Pharm Biomed Anal; 2008 Jul; 47(3):618-24. PubMed ID: 18339506
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
    Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
    Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
    Tokuma Y; Fujiwara T; Noguchi H
    Xenobiotica; 1987 Nov; 17(11):1341-9. PubMed ID: 3433803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amlodipine: a new calcium antagonist.
    Clavijo GA; de Clavijo IV; Weart CW
    Am J Hosp Pharm; 1994 Jan; 51(1):59-68. PubMed ID: 8135260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.